160 related articles for article (PubMed ID: 38834787)
21. CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.
Byun J; Lee SS; Sung YS; Shin Y; Yun J; Kim HS; Yu ES; Lee SG; Lee MG
Eur Radiol; 2019 Aug; 29(8):4427-4435. PubMed ID: 30569183
[TBL] [Abstract][Full Text] [Related]
22. Decreased portal vein attenuation and liver enhancement with reduced intravenous contrast dosage during the national iodinated contrast shortage of 2022.
Ranger R; Truong D; Thompson J
J Clin Imaging Sci; 2024; 14():13. PubMed ID: 38665595
[TBL] [Abstract][Full Text] [Related]
23. Prediction of viable tumor in hepatocellular carcinoma treated with transcatheter arterial chemoembolization: usefulness of attenuation value measurement at quadruple-phase helical computed tomography.
Kim SH; Lee WJ; Lim HK; Lim JH
J Comput Assist Tomogr; 2007; 31(2):198-203. PubMed ID: 17414753
[TBL] [Abstract][Full Text] [Related]
24. Individualized Contrast Media Application Based on Body Weight and Contrast Enhancement in Computed Tomography of Livers without Steatosis.
de Jong DJ; van Cooten VV; Veldhuis WB; de Jong PA; Kok M
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885457
[TBL] [Abstract][Full Text] [Related]
25. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
[TBL] [Abstract][Full Text] [Related]
26. Preoperative Evaluation of Liver Parenchyma of Potential Donors in Living Donor Liver Transplantation.
Novruzov N; Bayramov N; Mammadov E
Transplant Proc; 2019 Sep; 51(7):2379-2382. PubMed ID: 31474295
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images.
Reinert CP; Hinterleitner C; Fritz J; Nikolaou K; Horger M
Eur Radiol; 2019 Jan; 29(1):450-457. PubMed ID: 29915885
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal Changes in Liver Fat Content in Asymptomatic Adults: Hepatic Attenuation on Unenhanced CT as an Imaging Biomarker for Steatosis.
Hahn L; Reeder SB; Muñoz del Rio A; Pickhardt PJ
AJR Am J Roentgenol; 2015 Dec; 205(6):1167-72. PubMed ID: 26587921
[TBL] [Abstract][Full Text] [Related]
29. Natural history of hepatic steatosis: observed outcomes for subsequent liver and cardiovascular complications.
Pickhardt PJ; Hahn L; Muñoz del Rio A; Park SH; Reeder SB; Said A
AJR Am J Roentgenol; 2014 Apr; 202(4):752-8. PubMed ID: 24660702
[TBL] [Abstract][Full Text] [Related]
30. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.
Park SH; Kim PN; Kim KW; Lee SW; Yoon SE; Park SW; Ha HK; Lee MG; Hwang S; Lee SG; Yu ES; Cho EY
Radiology; 2006 Apr; 239(1):105-12. PubMed ID: 16484355
[TBL] [Abstract][Full Text] [Related]
31. Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver.
Jawahar A; Gonzalez B; Balasubramanian N; Adams W; Goldberg A
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):216-221. PubMed ID: 31584463
[TBL] [Abstract][Full Text] [Related]
32. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings.
Limanond P; Raman SS; Lassman C; Sayre J; Ghobrial RM; Busuttil RW; Saab S; Lu DS
Radiology; 2004 Jan; 230(1):276-80. PubMed ID: 14695401
[TBL] [Abstract][Full Text] [Related]
33. Split-bolus spectral multidetector CT of the pancreas: assessment of radiation dose and tumor conspicuity.
Brook OR; Gourtsoyianni S; Brook A; Siewert B; Kent T; Raptopoulos V
Radiology; 2013 Oct; 269(1):139-48. PubMed ID: 23674791
[TBL] [Abstract][Full Text] [Related]
34. Comparison of true unenhanced and virtual unenhanced (VUE) attenuation values in abdominopelvic single-source rapid kilovoltage-switching spectral CT.
Borhani AA; Kulzer M; Iranpour N; Ghodadra A; Sparrow M; Furlan A; Tublin ME
Abdom Radiol (NY); 2017 Mar; 42(3):710-717. PubMed ID: 27864600
[TBL] [Abstract][Full Text] [Related]
35. Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps.
Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Ikeda O; Yamashita Y
Radiology; 2020 Aug; 296(2):324-332. PubMed ID: 32452733
[TBL] [Abstract][Full Text] [Related]
36. Material density hepatic steatosis quantification on intravenous contrast-enhanced rapid kilovolt (peak)-switching single-source dual-energy computed tomography.
Patel BN; Kumbla RA; Berland LL; Fineberg NS; Morgan DE
J Comput Assist Tomogr; 2013; 37(6):904-10. PubMed ID: 24270112
[TBL] [Abstract][Full Text] [Related]
37. Quantification of Hepatic Steatosis on Dual-Energy CT in Comparison With MRI mDIXON-Quant Sequence in Breast Cancer.
Wang X; Pan X; Zhou W; Jing Z; Yu F; Wang Y; Zeng J; Wu J; Zeng X; Zhang J
J Comput Assist Tomogr; 2024 Jan-Feb 01; 48(1):64-71. PubMed ID: 37558648
[TBL] [Abstract][Full Text] [Related]
38. Effect of IV contrast on lumbar trabecular attenuation at routine abdominal CT: correlation with DXA and implications for opportunistic osteoporosis screening.
Pickhardt PJ; Lauder T; Pooler BD; Muñoz Del Rio A; Rosas H; Bruce RJ; Binkley N
Osteoporos Int; 2016 Jan; 27(1):147-52. PubMed ID: 26153046
[TBL] [Abstract][Full Text] [Related]
39. Clinical Importance of Incidental Homogeneous Renal Masses That Measure 10-40 mm and 21-39 HU at Portal Venous Phase CT: A 12-Institution Retrospective Cohort Study.
Corwin MT; Altinmakas E; Asch D; Bishop KA; Boge M; Curci NE; Ebada M; Elkassem AA; Fananapazir G; Fetzer DT; Gaballah AH; Gandhi D; Kampalath R; Lee S; Markese M; McInnes MDF; Patel NU; Remer EM; Rosasco S; Schieda N; Sweet DE; Smith AD; Taylor E; Silverman SG; Davenport MS
AJR Am J Roentgenol; 2021 Jul; 217(1):135-140. PubMed ID: 32845714
[No Abstract] [Full Text] [Related]
40. Intravenous contrast injection significantly affects bone mineral density measured on CT.
Pompe E; Willemink MJ; Dijkhuis GR; Verhaar HJ; Mohamed Hoesein FA; de Jong PA
Eur Radiol; 2015 Feb; 25(2):283-9. PubMed ID: 25187384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
